Health and Wellness | Johnson & Johnson reported that Spravato treated over 100,000 patients in 77 countries worldwide, including roughly 80,000 in the US alone. 

A first of its kind: US FDA-approved nasal spray available for treatment-resistant depression in America

Researchers discovered that the rare but deadly blood clots associated with Johnson & Johnson and AstraZeneca Plc's COVID-19 vaccines were triggered by an autoimmune response that some people may have a genetic predisposition to.

Genetics linked to rare blood clots from J&J and AstraZeneca Covid vaccines, researchers claim

In a major development, healthcare giant Johnson & Johnson has reached a tentative settlement to address an investigation by more than 40 states regarding allegations that the company misled consumers about the safety of its talc baby powder and other talc-based products, as reported by CNBC.

Johnson & Johnson agrees to $700 mn settlement in talc baby powder investigation

Johnson & Johnson is bidding adieu to its old, instantly recognisable 'cursive' logo that has been its brand identity for the last 136 years. The healthcare giant on Thursday (September 14) said it will replace the logo with a modern look that reflects its sharpened focus on pharmaceuticals and medical devices.

Johnson & Johnson has ditched its 136-year-old iconic logo. Know why

A US court ruled that Johnson & Johnson cannot use the bankruptcy of one of its subsidiaries as leverage to force thousands of cancer patients to withdraw their cases and accept a settlement offer. The appeals court made it clear that a company must be in "immediate, imminent, and clear" financial trouble before it can file for bankruptcy.

Johnson & Johnson's $8.9 bn settlement plan in jeopardy | World DNA

Here we bring you a quick round-up of all the latest news and top trending headlines from all across the globe. The Indian passport's rank has improved in the latest Henley Passport Index. India's rank has gone up from 87 to 80. Indian can now travel to 57 destinations without a visa. Watch to know more.

The world's strongest passport | Johnson & Johnson subsidiary files for bankruptcy

A Johnson & Johnson subsidiary is again asking a U.S. judge to pause tens of thousands of lawsuits alleging the company's baby powder and other talc products cause cancer, as it seeks to resolve the litigation in bankruptcy after a federal appeals court found its first attempt improper.

J&J talc unit asks judge to halt cancer lawsuits as it pursues $8.9 bln settlement

A Johnson & Johnson (J&J) subsidiary has once again requested an American judge to delay 38,000 lawsuits worth tens of thousands of dollars. These lawsuits accuse their baby powder and other talc products of causing cancer.

Johnson & Johnson unit seeks to halt 38,000 lawsuits over its alleged 'cancer causing' talc

Johnson and Johnson for its baby products and you probably know that the company faces lawsuits of its baby powder more than 90,000 lawsuits have been filed against the baby talc maker. The allegations are that the baby powder produced by the company was laced with asbestos.

Lawsuit over Johnson & Johnson's 'toxic' baby powder: Cancer victims blocking $8.9 bn deal

US pharma giant Johnson & Johnson has proposed an $8.9 bn settlement to resolve several lawsuits. The lawsuits allege that Johnson and Johnson's talcum powder products cause cancer. For several years now, J&J has been facing lawsuits of its talcum powder containing traces of asbestos.

Johnson & Johnson offers $8.9 bn talcum powder settlement | World Business News

Johnson & Johnson has agreed to pay $8.9 billion to settle lawsuits claiming that its talcum powder products caused cancer. The move will potentially end the years-long legal fight over the issue.

Johnson & Johnson to pay $8.9 billion to settle lawsuits over 'cancer-causing' talc

More than a month after Johnson & Johnson announced that it will stop the sale of its talc-based baby powder globally in 2023, the Indian state of Maharashtra on Friday cancelled the manufacturing licence of the pharmaceutical company.

India: Maharashtra cancels Johnson & Johnson baby powder manufacturing licence

The Maharashtra Food and Drug Administration (FDA) has revoked Johnson & Johnson's baby powder production license for its Mulund factory and ordered the corporation to remove the product from the market.

India: Maharashtra cancels j&j baby powder manufacturing licence over quality concerns

Johnson & Johnson will stop selling their controversial talcum powder which has been linked to multiple cases of cancer in women. The company rejected the cancer links, claiming the decision was influenced by 'evolving consumer trends'. Palki Sharma tells you more.

Gravitas: Johnson & Johnson to stop selling baby powder linked to cancer

US pharmaceutical giant Johnson & Johnson on Thursday announced that it will be discontinuing the sales of its controversial talc-based baby powder globally in 2023.

Johnson & Johnson to stop selling its talc-based baby powder globally in 2023 as lawsuits mount

Johnson & Johnson will stop selling talc-based baby powder globally in 2023, the drug maker said on Thursday, more than two years after it ended US sales of a product that drew thousands of consumer safety lawsuits.

Johnson & Johnson to end global sales of controversial talc-based baby powder

In a first, a South African citizen with a rare neurological disorder called Guillain-Barre Syndrome died after getting inoculated with Johnson & Johnson's COVID-19 vaccine.

South African with rare neurological disorder dies after getting inoculated by Johnson & Johnson's vaccine

Johnson & Johnson suspended sales forecasts for its Covid-19 vaccine during the American pharmaceutical giant's quarterly earnings call Tuesday, as demand lags behind that of shots by Moderna and Pfizer.

Johnson & Johnson suspends sales forecast for Covid vaccine

Expert advisers to the Centers for Disease Control and Prevention will meet Thursday to discuss what federal health officials see as a concerning increase in the rates of a rare but serious blood-clotting disorder linked to Johnson & Johnson’s coronavirus vaccine.

CDC panel will discuss blood clot risk linked to Johnson & Johnson vaccine

US pharmaceutical giant Johnson & Johnson on Friday announced plans to break up into two listed companies, separating its consumer health arm that sells Band-Aids and Tylenol from its pharmaceutical division.

Johnson & Johnson plans to split into two companies

Four manufacturers of prescription opioids won the pharmaceutical industry’s first major legal victory in the opioid crisis, turning aside claims by local California governments that they contributed substantially to the epidemic.

Opioid makers win major victory in California trial

People who received Johnson & Johnson's Covid-19 vaccine may benefit from a booster dose of Pfizer or Moderna, preliminary results of a US study published Wednesday showed.

Moderna or Pfizer booster works better for people vaccinated with J&J: Study

A clinical trial involving 2,600 young women in sub-Saharan Africa found that Johnson & Johnson's highly anticipated HIV vaccine did not offer adequate protection against the virus, the company told US health officials Tuesday.

Johnson & Johnson's 'Imbokodo' trial for HIV vaccine fails in sub-Saharan Africa

US pharma giant Johnson & Johnson has moved an application before the Central Drugs Standard Control Organisation (CDSCO) in India, seeking permission to conduct clinical trials of its single-dose Janssen vaccine against COVID-19 on adolescents (children of age group 12-17 years).

COVID-19: J&J applies for approval to conduct clinical trials on adolescents in India for single-dose vaccine

johnson-johnson

Johnson & Johnson, News on Johnson & Johnson, stories on Johnson & Johnson, articles on Johnson & Johnson, Johnson & Johnson stories at Wion, Johnson & Johnson news, Johnson & Johnson latest news

johnson johnson